之前聽到關於流感(A.B型)藥物
|
Oseltamivir (Tamiflu®) |
Zanamivir (Relenza®) |
FDA核准上市 |
1999.10.27 |
1999.7.26 |
|
||
|
||
Dosage form |
Oral |
Inhalation (diskhaler) |
75 mg /cap |
5 mg/inhalation |
|
Indication |
|
|
Dose |
Avian influenza ① 治療:75 mg BID × 5 days ② 預防:75 mg QD × 7~10 days Influenza, Viruses Types A and B ① 治療:75 mg BID × 5 days ② 預防:75 mg QD × 10 days (~ 6 weeks) |
Avian influenza ① 治療:10 mg (× 2 inhalation) BID × 7~10 days ② 預防:10 mg (× 2 inhalation) QD × 7~10 days Influenza, Viruses Types A and B ① 治療:day 1=> 10 mg Q2H,then Q12H × 5 days ② 預防:家裡照護 10 mg QD × 10 days ③ community setting 10 mg QD × 28 days |
Dose adjustment |
renal failure
|
none |
Contraindication |
hypersensitivity to oseltamivir phosphate or any other component of the product |
hypersensitivity to zanamivir or any component of the product including lactose (milk proteins) |
Precaution |
① 使用可能出現譫妄或行為異常,尤其是幼兒 ② 若要使用LAIV,合併zanamivir,須於使用zanamivir前2週接種或是於之後48小時接種。 ③ skin reactions, serious |
|
孕級: |
C |
C |
Adverse effects |
常見: ① Abdominal pain (2% to 5% ), Nausea (4% to 10% ), Vomiting (2% to 15% ) ② 失眠 ③ 支氣管炎 嚴重: ① Cardiac dysrhythmia ② Erythema multiforme (rare ), Facial swelling, Stevens-Johnson syndrome (rare ), Toxic epidermal necrolysis (rare ) ③ Hepatitis ④ Seizure ⑤ Abnormal behavior, Delirium |
常見: ① 關節疼痛(< 1.5 %)、急性RA ② 昏沉困倦(1~2 %) ③ Cough (小孩16 % ) ④ Nasal symptom (小孩20 % ) ⑤ 喉嚨痛 ⑥ 腹瀉 ⑦ 頭痛 嚴重: ① Seizure ② Cardiac dysrhythmia ③ Facial edema, Rash, Urticaria ④ Abnormal behavior, Delirium ⑤ Bronchospasm ⑥ Respiratory depression, Respiratory distress |
Monitor |
|
|
注意 |
2009: H1N1 influenza 100 % 抗藥性 |
|